sábado, 11 de junio de 2022

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies - The Lancet Infectious Diseases

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies - The Lancet Infectious Diseases

No hay comentarios:

Publicar un comentario